Truvestments Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688 | Hold |
46
| – | – | ﹤0.01% | 894 |
|
|
2025
Q1 | $539 | Hold |
46
| – | – | ﹤0.01% | 957 |
|
|
2024
Q4 | $1.05K | Hold |
46
| – | – | ﹤0.01% | 917 |
|
|
2024
Q3 | $1.93K | Buy |
+46
| New | +$1.93K | ﹤0.01% | 801 |
|
|
2024
Q2 | – | Sell |
-46
| Closed | -$2.34K | – | 515 |
|
|
2024
Q1 | $2.34K | Hold |
46
| – | – | ﹤0.01% | 609 |
|
|
2023
Q4 | $891 | Hold |
46
| – | – | ﹤0.01% | 715 |
|
|
2023
Q3 | $731 | Hold |
46
| – | – | ﹤0.01% | 638 |
|
|
2023
Q2 | $768 | Hold |
46
| – | – | ﹤0.01% | 642 |
|
|
2023
Q1 | $648 | Hold |
46
| – | – | ﹤0.01% | 628 |
|
|
2022
Q4 | $471 | Hold |
46
| – | – | ﹤0.01% | 871 |
|
|
2022
Q3 | $1K | Sell |
46
-20
| -30% | -$435 | ﹤0.01% | 596 |
|
|
2022
Q2 | $1K | Buy |
+66
| New | +$1K | ﹤0.01% | 612 |
|
|
2022
Q1 | – | Sell |
-66
| Closed | -$6K | – | 408 |
|
|
2021
Q4 | $6K | Hold |
66
| – | – | ﹤0.01% | 458 |
|
|
2021
Q3 | $10K | Hold |
66
| – | – | 0.01% | 379 |
|
|
2021
Q2 | $12K | Hold |
66
| – | – | 0.01% | 370 |
|
|
2021
Q1 | $16K | Hold |
66
| – | – | 0.01% | 395 |
|
|
2020
Q4 | $18K | Buy |
+66
| New | +$18K | 0.01% | 376 |
|
|
2020
Q3 | – | Sell |
-66
| Closed | -$21K | – | 465 |
|
|
2020
Q2 | $21K | Buy |
+66
| New | +$21K | 0.02% | 299 |
|
|
2019
Q4 | – | Sell |
-113
| Closed | -$6K | – | 424 |
|
|
2019
Q3 | $6K | Sell |
113
-12
| -10% | -$637 | ﹤0.01% | 553 |
|
|
2019
Q2 | $6K | Hold |
125
| – | – | ﹤0.01% | 597 |
|
|
2019
Q1 | $7K | Buy |
+125
| New | +$7K | 0.01% | 563 |
|
|
2018
Q3 | $8K | Buy |
+131
| New | +$8K | ﹤0.01% | 679 |
|